AFFiRiS
AFFiRiS is a clinical-stage biopharmaceutical company that develops Specific Active Immunotherapies (SAIT) for chronic human diseases using its proprietary AFFITOME technology. The company focuses on identifying and targeting proteins involved in the progression of conditions such as hypercholesterolemia and neurodegenerative diseases. Its treatments are designed to induce long-lasting immune responses that require less frequent dosing than current symptom-management therapies.
Biotechnology
Pharmaceuticals
Healthcare
Funding summary
- Total raised
- €35.0M
- Funding rounds
- 2
Investors in AFFiRiS
Investors on record for AFFiRiS. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like AFFiRiS?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors